Warning letter
Memorial Blood Centers: warning letter of Nov 14, 2005
FDA warning letter UCM075693 · Minneapolis District Office
Key facts
| Reference number | UCM075693 |
|---|---|
| Company | Memorial Blood Centers |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Nov 14, 2005 |
| Posted date | Nov 14, 2005 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 211, 211.100(b), 606.100(c), 606.100(b) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: